12:50 PM, 20th Jan 2026
Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 inter alia to consider and approve Un-audited Financial Results (Standalone & Consolidated) of the Company for the Third Quarter and Nine Months ended on 31st December 2025.